ICPT - Intercept Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue130,95624,9512,782
Cost of Revenue1,371--
Gross Profit129,58524,9512,782
Operating Expenses
Research Development191,499153,893112,696
Selling General and Administrative273,698273,596119,242
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-335,612-402,538-229,156
Income from Continuing Operations
Total Other Income/Expenses Net4,5163,9042,727
Earnings Before Interest and Taxes-331,096-398,634-226,429
Interest Expense29,27114,19614,196
Income Before Tax-360,367-412,830-226,429
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-360,367-412,830-226,429
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-360,367-412,830-226,429
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-360,367-412,830-226,429